Synutra International (Synutra International) Debt-to-Equity : 3.98 (As of Dec. 2016)

View and export this data going back to 2004. Start your Free Trial

What is Synutra International Debt-to-Equity?

Synutra International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2016 was $239.6 Mil. Synutra International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2016 was $278.3 Mil. Synutra International's Total Stockholders Equity for the quarter that ended in Dec. 2016 was $130.1 Mil. Synutra International's debt to equity for the quarter that ended in Dec. 2016 was 3.98.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Synutra International's Debt-to-Equity or its related term are showing as below:

SYUT's Debt-to-Equity is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 0.41
* Ranked among companies with meaningful Debt-to-Equity only.

Synutra International Debt-to-Equity Historical Data

The historical data trend for Synutra International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synutra International Debt-to-Equity Chart

Synutra International Annual Data

Trend

Mar07

Mar08

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Debt-to-Equity

Get a 7-Day Free Trial

2.34

11.13

6.12

3.83

3.85

Synutra International Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16
Debt-to-Equity	Get a 7-Day Free Trial															3.83	3.85	4.18	4.04	3.98

Competitive Comparison of Synutra International's Debt-to-Equity

For the Packaged Foods subindustry, Synutra International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synutra International's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Synutra International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Synutra International's Debt-to-Equity falls into.

Synutra International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Synutra International's Debt to Equity Ratio for the fiscal year that ended in Mar. 2016 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(190.679	+	322.827)	/	133.241
	=	3.85

Synutra International's Debt to Equity Ratio for the quarter that ended in Dec. 2016 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(239.588	+	278.319)	/	130.061
	=	3.98

Synutra International (NAS:SYUT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Synutra International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Synutra International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Synutra International (Synutra International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Synutra International Inc (NAS:SYUT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.synutra.com

Synutra International Inc was formed on October 30, 1998. The Company is engaged in the production, distribution & sales of dairy based nutritional products under Shengyuan or Synutra line of brands in China. Its other nutritional product includes prepared foods, nutritional ingredients & supplements. It is focused on selling powdered formula products for infants and adults, and is also engaged in other nutritional product offerings, such as prepared foods and certain nutritional supplements. It sells the products through an extensive nationwide sales and distribution network covering all provinces and provincial-level municipalities in mainland China. It has three reportable segments; nutritional food, nutritional supplement and other business. The Nutritional Food segment includes the sale of powdered infant and adult formula products, with brands including Super, My Angel and Dutch Cow, as well as the sale of prepared foods under the Huiliduo brand; Nutritional Supplement: includes the production and sale of nutritional supplements such as chondroitin sulfate to third parties, and microencapsulated Docosahexanoic Acid ("DHA") and Arachidonic Acid ("ARA") to the nutritional food segment for use in powdered formula production; and Other Business includes non-core businesses such as ancillary sales of excess or unusable ingredients and materials to industrial customers, providing genetic diagnostic services for new born babies, and sales of cosmetics to pregnant women. Its business requires certain key raw materials, such as milk powder and whey powder. The Company competes with both multinational and domestic infant formula producers.

Executives

Warburg Pincus & Co.	10 percent owner	450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Warburg Pincus Llc	10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus Partners Llc	10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
Joseph P. Landy	10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Charles R Kaye	10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus Private Equity Ix, L.p.	10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus Ix Llc	10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
David Hui Li	director	C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017

Synutra International (Synutra International) Headlines

No Headlines